MedWatch

The Medwatch Industry Analysis 2013

Are you up to date? On November 15 we present the Medwatch Industry Analysis 2013 at a morning conference in Copenhagen.

Foto: Colourbox

The Medwatch Industry Analysis 2013 is conducted by Medwatch with the contribution of Medico Insight+ (M3 Research and A&B Analyse), Sydbank, Dansk Aktie Analyse and Novo A/S. It includes:

- Analyses of public life science companies from Denmark and abroad for the current year

- An extensive survey of patient attitudes to their treatment within a long line of disease areas

- The most important events in the global life science industry in 2013

- Key figures from the most recent financial reports from the biggest Danish life science companies

At the morning conference, the main conclusions from the report will be presented and a printed version of the actual report will be given to the participants.

 

Program:

7.45-8.00: Introduction to The Medwatch Industry Analysis 2013 by editor Henrik Tüchsen, Medwatch.

8.00-8.45: Medico Insight+ presents its major patient survey and a smaller population survey.

8.45-9.15: Time to meet colleagues from the industry and journalists from Medwatch.

We serve coffee, fruit and pastries.

 

Time and place: Friday November 15 in the meeting hall in JP/Politikens Hus, Rådhuspladsen 37, Copenhagen.Entrance from Vestergade 30, Copenhagen.

Price: DKK 495 per person* (Free to attend for Medwatch Plus subscribers)

Signing up: Send an e-mail to medwatch@medwatch.dk

More info about Medwatch Plus:  70777441 – medwatch@infowatch.dk

* No-shows are charged a fee of DKK 495

(Please note that all presentations are in Danish)

Mere fra MedWatch

Biontech opretter mRNA-center i Australien

Det tyske biotekselskab Biontech, som står bag den mest udbredte vaccine mod covid-19, opretter nu et center i Australien, der både skal videreudvikle nye vacciner baseret på mRNA-teknologien samt kunne producere dem.

Her er de vigtigste nyheder fra MedWatch i uge 40

Zealand Pharma hentede den seneste uge 786 mio kr. gennem en rettet emission, mens biotekselskabet Biograil hev et partnerskab med den amerikanske gigant Eli Lilly i land. Og så blev der udskrevet folketingsvalg, som fik særligt ét spørgsmål til at fylde i vælgernes bevidsthed. Gik du glip af noget?

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier